Kiniksa Pharmaceuticals Ownership 2024 | Who Owns Kiniksa Pharmaceuticals Now?


OverviewForecastRevenueFinancialsChartTranscripts

Institutional Ownership

55.34%

Insider Ownership

4.28%

Retail Ownership

40.38%

Institutional Holders

160.00

Kiniksa Pharmaceuticals Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BLACKROCK INC.5.96%0.00%4,193,9071,013,31931.86%82,745,786Mar 31, 2024
FAIRMOUNT FUNDS MANAGEMENT LLC4.55%6.89%3,204,841321,62011.15%63,231,513Mar 31, 2024
HHLR ADVISORS, LTD.4.46%1.34%3,135,7353,135,735100.00%61,868,052Mar 31, 2024
VANGUARD GROUP INC4.24%0.00%2,981,89416,5950.56%58,832,768Mar 31, 2024
BAKER BROS. ADVISORS LP3.99%0.70%2,809,577--55,432,954Mar 31, 2024
RUBRIC CAPITAL MANAGEMENT LP3.12%1.28%2,196,009-711,492-24.47%43,327,258Mar 31, 2024
STATE STREET CORP2.68%0.00%1,888,544342,44822.15%37,260,973Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA2.08%0.03%1,460,633-110,183-7.01%28,818,289Mar 31, 2024
BRAIDWELL LP1.98%0.89%1,392,7161,392,716100.00%27,478,287Mar 31, 2024
MORGAN STANLEY1.81%0.00%1,270,613-324,866-20.36%25,069,195Mar 31, 2024
NUVEEN ASSET MANAGEMENT, LLC1.18%0.00%831,099420,075102.20%16,397,584Mar 31, 2024
GOLDMAN SACHS GROUP INC1.08%0.00%760,107-149,105-16.40%14,996,911Mar 31, 2024
GEODE CAPITAL MANAGEMENT, LLC1.03%0.00%725,51125,8983.70%14,316,283Mar 31, 2024
ARROWMARK COLORADO HOLDINGS LLC0.95%0.15%666,976-47,903-6.70%13,159,436Mar 31, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC0.92%0.45%648,087-74,301-10.29%12,786,757Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.92%1.56%646,16330,4704.95%12,748,796Mar 31, 2024
DRIEHAUS CAPITAL MANAGEMENT LLC0.88%0.12%622,540-39,175-5.92%12,282,714Mar 31, 2024
RICE HALL JAMES & ASSOCIATES, LLC0.88%0.70%618,798-17,231-2.71%12,208,885Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.72%0.00%506,299156,54644.76%9,989,280Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC0.71%1.03%500,000-100,000-16.67%9,865,000Mar 31, 2024

Kiniksa Pharmaceuticals's largest institutional shareholder is BLACKROCK INC., holding 5.96% of the company's total share outstanding, currently valued at $82.75M. The top 10 institutional shareholders own together 34.86% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
FAIRMOUNT FUNDS MANAGEMENT LLC4.55%6.89%3,204,841321,62011.15%63,231,513Mar 31, 2024
ALTITUDE CREST PARTNERS INC.0.57%3.38%400,441-55,600-12.19%7,900,701Mar 31, 2024
PARKMAN HEALTHCARE PARTNERS LLC0.92%1.56%646,16330,4704.95%12,748,796Mar 31, 2024
LION POINT CAPITAL, LP0.19%1.44%130,691--2,578,533Mar 31, 2024
HHLR ADVISORS, LTD.4.46%1.34%3,135,7353,135,735100.00%61,868,052Mar 31, 2024
RUBRIC CAPITAL MANAGEMENT LP3.12%1.28%2,196,009-711,492-24.47%43,327,258Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC0.71%1.03%500,000-100,000-16.67%9,865,000Mar 31, 2024
BRAIDWELL LP1.98%0.89%1,392,7161,392,716100.00%27,478,287Mar 31, 2024
HUSSMAN STRATEGIC ADVISORS, INC.0.22%0.72%157,500157,500100.00%3,107,475Mar 31, 2024
RICE HALL JAMES & ASSOCIATES, LLC0.88%0.70%618,798-17,231-2.71%12,208,885Mar 31, 2024
BAKER BROS. ADVISORS LP3.99%0.70%2,809,577--55,432,954Mar 31, 2024
ESSEX INVESTMENT MANAGEMENT CO LLC0.25%0.67%172,7408500.49%3,408,160Mar 31, 2024
HIGHVISTA STRATEGIES LLC0.13%0.62%88,688--1,749,814Mar 31, 2024
BIRCHVIEW CAPITAL, LP0.04%0.48%30,000--591,900Mar 31, 2024
OPTIONS SOLUTIONS, LLC0.06%0.45%40,20540,205100.00%793,245Mar 31, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC0.92%0.45%648,087-74,301-10.29%12,786,757Mar 31, 2024
JACKSON CREEK INVESTMENT ADVISORS LLC0.08%0.38%54,38454,384100.00%1,073,000Mar 31, 2024
LINDEN THOMAS ADVISORY SERVICES, LLC0.17%0.37%116,3811,8311.60%2,296,197Mar 31, 2024
TEJARA CAPITAL LTD0.06%0.31%42,649-52,500-55.18%841,465Mar 31, 2024
ADAR1 CAPITAL MANAGEMENT, LLC0.08%0.27%59,700-45,300-43.14%1,177,881Mar 31, 2024

The largest Kiniksa Pharmaceuticals shareholder by % of total assets is FAIRMOUNT FUNDS MANAGEMENT LLC. The company owns 3.20M shares of Kiniksa Pharmaceuticals (KNSA), representing 6.89% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
HHLR ADVISORS, LTD.4.46%1.34%3,135,7353,135,735100.00%61,868,052Mar 31, 2024
BRAIDWELL LP1.98%0.89%1,392,7161,392,716100.00%27,478,287Mar 31, 2024
BLACKROCK INC.5.96%0.00%4,193,9071,013,31931.86%82,745,786Mar 31, 2024
NUVEEN ASSET MANAGEMENT, LLC1.18%0.00%831,099420,075102.20%16,397,584Mar 31, 2024
STATE STREET CORP2.68%0.00%1,888,544342,44822.15%37,260,973Mar 31, 2024
FAIRMOUNT FUNDS MANAGEMENT LLC4.55%6.89%3,204,841321,62011.15%63,231,513Mar 31, 2024
PEREGRINE CAPITAL MANAGEMENT LLC0.34%0.13%236,045236,045100.00%4,657,168Mar 31, 2024
KNIGHTS OF COLUMBUS ASSET ADVISORS LLC0.23%0.23%162,283162,283100.00%3,201,844Mar 31, 2024
BANK OF AMERICA CORP /DE/0.30%0.00%212,505161,962320.44%4,192,724,000Mar 31, 2024
HUSSMAN STRATEGIC ADVISORS, INC.0.22%0.72%157,500157,500100.00%3,107,475Mar 31, 2024
DIMENSIONAL FUND ADVISORS LP0.72%0.00%506,299156,54644.76%9,989,280Mar 31, 2024
CITIGROUP INC0.27%0.00%191,020144,662312.05%3,768,825Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.19%0.00%131,800131,800100.00%2,600,414Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.19%0.00%131,223131,223100.00%2,589,030Mar 31, 2024
NORDEA INVESTMENT MANAGEMENT AB0.18%0.00%126,742126,742100.00%2,486,678Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.17%0.00%122,100122,100100.00%2,409,033Mar 31, 2024
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP0.26%0.00%185,813109,061142.10%3,666,000Mar 31, 2024
ACADIAN ASSET MANAGEMENT LLC0.23%0.01%164,568103,120167.82%3,240,000Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.12%0.00%84,49384,493100.00%1,667,047Mar 31, 2024
SEI INVESTMENTS CO0.10%0.00%73,48173,481100.00%1,449,790Mar 31, 2024

As of Mar 31 2024, Kiniksa Pharmaceuticals's largest institutional buyer is HHLR ADVISORS, LTD.. The company purchased 3.14M stocks of KNSA, valued at $61.87M.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
RUBRIC CAPITAL MANAGEMENT LP3.12%1.28%2,196,009-711,492-24.47%43,327,258Mar 31, 2024
GMT CAPITAL CORP----341,553-100.00%-Mar 31, 2024
WALLEYE CAPITAL LLC----327,332-100.00%-Mar 31, 2024
MORGAN STANLEY1.81%0.00%1,270,613-324,866-20.36%25,069,195Mar 31, 2024
CAPTION MANAGEMENT, LLC----296,200-100.00%-Mar 31, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND----227,500-100.00%-Mar 31, 2024
MILLENNIUM MANAGEMENT LLC0.34%0.00%239,409-188,926-44.11%4,723,540Mar 31, 2024
STEMPOINT CAPITAL LP----183,102-100.00%-Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP----150,000-100.00%-Mar 31, 2024
GOLDMAN SACHS GROUP INC1.08%0.00%760,107-149,105-16.40%14,996,911Mar 31, 2024
BARCLAYS PLC0.06%0.00%42,147-143,609-77.31%831,000Mar 31, 2024
PICTET ASSET MANAGEMENT HOLDING SA2.08%0.03%1,460,633-110,183-7.01%28,818,289Mar 31, 2024
CITADEL ADVISORS LLC0.15%0.00%105,290-109,406-50.96%2,077,372Mar 31, 2024
TANG CAPITAL MANAGEMENT LLC0.71%1.03%500,000-100,000-16.67%9,865,000Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----83,572-100.00%-Mar 31, 2024
D. E. SHAW & CO., INC.0.32%0.00%221,853-82,752-27.17%4,377,160Mar 31, 2024
HRT FINANCIAL LP----74,866-100.00%-Mar 31, 2024
GRANAHAN INVESTMENT MANAGEMENT, LLC0.92%0.45%648,087-74,301-10.29%12,786,757Mar 31, 2024
CHARLES SCHWAB INVESTMENT MANAGEMENT INC0.12%0.00%84,155-72,586-46.31%1,660,378Mar 31, 2024
AQR CAPITAL MANAGEMENT LLC0.23%0.01%159,323-68,722-30.14%3,143,442Mar 31, 2024

As of Mar 31 2024, Kiniksa Pharmaceuticals's biggest institutional seller is RUBRIC CAPITAL MANAGEMENT LP. The company sold -0.71M shares of KNSA, valued at $43.33M.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BRAIDWELL LP1.98%0.89%1,392,7161,392,716100.00%27,478,287Mar 31, 2024
PEREGRINE CAPITAL MANAGEMENT LLC0.34%0.13%236,045236,045100.00%4,657,168Mar 31, 2024
KNIGHTS OF COLUMBUS ASSET ADVISORS LLC0.23%0.23%162,283162,283100.00%3,201,844Mar 31, 2024
HUSSMAN STRATEGIC ADVISORS, INC.0.22%0.72%157,500157,500100.00%3,107,475Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.19%0.00%131,800131,800100.00%2,600,414Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.19%0.00%131,223131,223100.00%2,589,030Mar 31, 2024
NORDEA INVESTMENT MANAGEMENT AB0.18%0.00%126,742126,742100.00%2,486,678Mar 31, 2024
SUSQUEHANNA INTERNATIONAL GROUP, LLP0.17%0.00%122,100122,100100.00%2,409,033Mar 31, 2024
WELLINGTON MANAGEMENT GROUP LLP0.12%0.00%84,49384,493100.00%1,667,047Mar 31, 2024
BREVAN HOWARD CAPITAL MANAGEMENT LP0.09%0.01%59,95459,954100.00%1,182,892Mar 31, 2024
OPTIONS SOLUTIONS, LLC0.06%0.45%40,20540,205100.00%793,245Mar 31, 2024
VOLORIDGE INVESTMENT MANAGEMENT, LLC0.05%0.00%34,06234,062100.00%672,043Mar 31, 2024
CERITY PARTNERS LLC0.04%0.00%29,68329,683100.00%585,645Mar 31, 2024
NEW YORK LIFE INVESTMENT MANAGEMENT LLC0.03%0.00%17,85617,856100.00%352,299Mar 31, 2024
HSBC HOLDINGS PLC0.02%0.00%16,35616,356100.00%322,704Mar 31, 2024
PEAK6 INVESTMENTS LLC0.02%0.00%15,00015,000100.00%295,950Mar 31, 2024
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM0.02%0.00%13,46713,467100.00%144,905Mar 31, 2024
MARINER, LLC0.02%0.00%13,42713,427100.00%264,915,000Mar 31, 2024
HARBOR CAPITAL ADVISORS, INC.0.02%0.03%13,14213,142100.00%259,000Mar 31, 2024
BAYESIAN CAPITAL MANAGEMENT, LP0.02%0.02%11,24511,245100.00%221,864Mar 31, 2024
ALGERT GLOBAL LLC0.01%0.01%10,44710,447100.00%206,000Mar 31, 2024
CAPTION MANAGEMENT, LLC0.01%0.00%6,0006,000100.00%118,380Mar 31, 2024
SIMPLEX TRADING, LLC0.01%0.00%5,0495,049100.00%99,000Mar 31, 2024
GROUP ONE TRADING, L.P.0.00%0.00%2,1752,175100.00%42,913Mar 31, 2024
VIRTUS FUND ADVISERS, LLC0.00%0.09%1,2361,236100.00%24,386Mar 31, 2024
PACER ADVISORS, INC.0.00%-660660100.00%13,022Mar 31, 2024
NATIONAL BANK OF CANADA /FI/0.00%-500500100.00%9,761Mar 31, 2024
US BANCORP \DE\0.00%-116116100.00%2,289Mar 31, 2024
NELSON, VAN DENBURG & CAMPBELL WEALTH MANAGEMENT GROUP, LLC--3434100.00%670Mar 31, 2024
RIGGS ASSET MANAGMENT CO. INC.-0.00%3030100.00%592Mar 31, 2024

Kiniksa Pharmaceuticals's largest new institutional shareholder by number of shares is BRAIDWELL LP, purchased 1.39M shares, valued at $27.48M, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
GMT CAPITAL CORP----341,553-100.00%-Mar 31, 2024
WALLEYE CAPITAL LLC----327,332-100.00%-Mar 31, 2024
CAPTION MANAGEMENT, LLC----296,200-100.00%-Mar 31, 2024
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND----227,500-100.00%-Mar 31, 2024
STEMPOINT CAPITAL LP----183,102-100.00%-Mar 31, 2024
LOGOS GLOBAL MANAGEMENT LP----150,000-100.00%-Mar 31, 2024
EXODUSPOINT CAPITAL MANAGEMENT, LP----83,572-100.00%-Mar 31, 2024
HRT FINANCIAL LP----74,866-100.00%-Mar 31, 2024
ENSIGN PEAK ADVISORS, INC----66,443-100.00%-Mar 31, 2024
ADVISORY RESEARCH INC----65,450-100.00%-Mar 31, 2024
OPALEYE MANAGEMENT INC.----37,500-100.00%-Mar 31, 2024
WALLEYE TRADING LLC----21,424-100.00%-Mar 31, 2024
ENVESTNET ASSET MANAGEMENT INC----14,509-100.00%-Mar 31, 2024
FOX RUN MANAGEMENT, L.L.C.----12,546-100.00%-Mar 31, 2024
Y-INTERCEPT (HONG KONG) LTD----12,180-100.00%-Mar 31, 2024
DYNAMIC TECHNOLOGY LAB PRIVATE LTD----12,160-100.00%-Mar 31, 2024
STATE OF WYOMING----2,342-100.00%-Mar 31, 2024
ENTRYPOINT CAPITAL, LLC----1,743-100.00%-Mar 31, 2024
NEWBRIDGE FINANCIAL SERVICES GROUP, INC.----300-100.00%-Mar 31, 2024
PLANNED SOLUTIONS, INC.----200-100.00%-Mar 31, 2024
COVESTOR LTD----53-100.00%-Mar 31, 2024

Kiniksa Pharmaceuticals's largest sold out institutional shareholder by shares sold is GMT CAPITAL CORP, sold -0.34M shares, valued at -, as of undefined.

Kiniksa Pharmaceuticals Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
WANGER ADVISORS TRUST0.43%272,453--Dec 31, 2023
COLUMBIA ACORN TRUST0.32%1,098,682--Dec 31, 2023
VANGUARD VALLEY FORGE FUNDS0.04%21,265--Dec 31, 2023
FORUM FUNDS II0.01%13,176--Jan 31, 2024
Humankind Benefit Corp0.01%248--Dec 31, 2023
DRIEHAUS MUTUAL FUNDS0.01%80,01121,68237.17%Dec 29, 2023
VANGUARD INDEX FUNDS0.01%3,086,260490,11018.88%Dec 31, 2023
CLEARWATER INVESTMENT TRUST0.01%47,116--Dec 29, 2023
ALPS ETF Trust0.00%43,040-25,965-37.63%Feb 29, 2024
JAMES ADVANTAGE FUNDS0.00%6,909--Dec 31, 2023
Destra Investment Trust0.00%5,116-2,023-28.34%Dec 31, 2023
TIAA SEPARATE ACCOUNT VA 10.00%706--Dec 31, 2023
VANGUARD EXPLORER FUND0.00%36,699--Jan 31, 2024
TIAA-CREF LIFE FUNDS0.00%7,893-138-1.72%Dec 31, 2023
INVESCO EXCHANGE-TRADED FUND TRUST0.00%186,740--Jan 31, 2024
Nushares ETF Trust0.00%14,683--Jan 31, 2024
TIMOTHY PLAN0.00%6,920--Mar 31, 2024
VICTORY PORTFOLIOS0.00%43,640--Dec 31, 2023
ProFunds0.00%10,6465,00988.86%Jan 31, 2024
VANGUARD HORIZON FUNDS0.00%22,257--Dec 31, 2023
OHIO NATIONAL FUND INC0.00%17,844--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%19,941--Dec 31, 2023
Brinker Capital Destinations Trust0.00%40,976-16,853-29.14%Feb 29, 2024
Direxion Shares ETF Trust0.00%92,039-17,202-15.75%Jan 31, 2024
VANGUARD VARIABLE INSURANCE FUNDS0.00%27,696--Dec 31, 2023
VANGUARD WORLD FUND0.00%96,4312,1062.23%Feb 29, 2024
Trust for Advised Portfolios0.00%5,797--Dec 31, 2023
Dimensional ETF Trust0.00%110,91381,213273.44%Jan 31, 2024
GPS Funds I0.00%978--Dec 31, 2023
AMERICAN CENTURY ETF TRUST0.00%21,7292,21311.34%Feb 29, 2024
Invesco Exchange-Traded Self-Indexed Fund Trust0.00%41,73130,954287.22%Feb 29, 2024
NEW COVENANT FUNDS0.00%801--Dec 31, 2023
PUTNAM ASSET ALLOCATION FUNDS0.00%375-18,666-98.03%Feb 29, 2024
Meeder Funds0.00%496--Mar 31, 2024
THRIVENT MUTUAL FUNDS0.00%6,122--Jan 31, 2024
VANGUARD SCOTTSDALE FUNDS0.00%137,40013,95011.30%Feb 29, 2024
VANGUARD WELLINGTON FUND0.00%21,7009,35375.75%Feb 29, 2024
Victory Portfolios II0.00%3,036-3,391-52.76%Dec 31, 2023
RBB FUND, INC.0.00%4,885--Feb 29, 2024
SEI INSTITUTIONAL MANAGED TRUST0.00%141,651-90,335-38.94%Dec 31, 2023
ALLSPRING MASTER TRUST0.00%3,029--Feb 29, 2024
Pacer Funds Trust0.00%1,637--Jan 31, 2024
NORTHERN FUNDS0.00%30,323-569-1.84%Dec 29, 2023
MUTUAL FUND SERIES TRUST0.00%110,000--Dec 31, 2023
THRIVENT SERIES FUND INC0.00%3,209--Dec 29, 2023
PGIM ETF TRUST0.00%1,914--Feb 29, 2024
WILSHIRE MUTUAL FUNDS INC0.00%5,691--Dec 31, 2023
HC CAPITAL TRUST0.00%442--Dec 31, 2023
MORGAN STANLEY PATHWAY FUNDS0.00%1,073--Feb 29, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%11,321-153,480-93.13%Dec 31, 2023
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.00%514--Dec 31, 2023
Advisors' Inner Circle Fund III0.00%1021821.43%Jan 31, 2024
SEI INSTITUTIONAL INVESTMENTS TRUST0.00%126,55442,35950.31%Feb 29, 2024
JOHN HANCOCK VARIABLE INSURANCE TRUST0.00%12,369-432-3.37%Dec 31, 2023
COLUMBIA FUNDS SERIES TRUST I0.00%27,381--Feb 29, 2024
Invesco Exchange-Traded Fund Trust II0.00%94333053.83%Feb 29, 2024
MASSMUTUAL SELECT FUNDS0.00%2,269--Dec 31, 2023
Bridge Builder Trust0.00%13,4858987.13%Dec 31, 2023
John Hancock Funds II0.00%3,468--Feb 29, 2024

Kiniksa Pharmaceuticals's largest mutual fund holder by % of total assets is "WANGER ADVISORS TRUST", owning 272.45K shares, compromising 0.43% of its total assets.

Kiniksa Pharmaceuticals Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 241608.84%
31 Dec, 231473.52%
30 Sep, 231426.77%
30 Jun, 23133-3.62%
31 Mar, 231383.76%
31 Dec, 2213317.70%
30 Sep, 2211318.95%
30 Jun, 2295-5.94%
31 Mar, 22101-5.61%
31 Dec, 211070.94%
30 Sep, 21106-6.19%
30 Jun, 21113-1.74%
31 Mar, 211151.77%
31 Dec, 201134.63%
30 Sep, 2010813.68%
30 Jun, 209525.00%
31 Mar, 207624.59%
31 Dec, 196115.09%
30 Sep, 1953-13.11%
30 Jun, 19618.93%
31 Mar, 19567.69%
31 Dec, 1852-3.70%
30 Sep, 185431.71%
30 Jun, 1841-

As of 31 Mar 24, 160 institutions are holding Kiniksa Pharmaceuticals's shares, representing an increase of 8.84% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2438,944,11213.89%
31 Dec, 2334,195,892-1.41%
30 Sep, 2334,684,4169.13%
30 Jun, 2331,782,4990.21%
31 Mar, 2331,715,9274.86%
31 Dec, 2230,244,9341.09%
30 Sep, 2229,920,261-0.02%
30 Jun, 2229,927,684-2.67%
31 Mar, 2230,749,7174.89%
31 Dec, 2129,316,4171.04%
30 Sep, 2129,014,1350.83%
30 Jun, 2128,774,053-0.74%
31 Mar, 2128,987,548-2.59%
31 Dec, 2029,759,7753.78%
30 Sep, 2028,676,86335.67%
30 Jun, 2021,136,79419.49%
31 Mar, 2017,688,96617.04%
31 Dec, 1915,113,844-2.72%
30 Sep, 1915,536,525-6.27%
30 Jun, 1916,575,9831.56%
31 Mar, 1916,320,89318.97%
31 Dec, 1813,718,366-4.87%
30 Sep, 1814,420,957-16.46%
30 Jun, 1817,262,299-

Kiniksa Pharmaceuticals (KNSA) has 38.94M shares outstanding as of 31 Mar 24, up 13.89% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2455.34%2.33%
31 Dec, 2348.72%1.98%
30 Sep, 2349.61%2.39%
30 Jun, 2345.57%2.20%
31 Mar, 2345.47%2.41%
31 Dec, 2243.45%2.34%
30 Sep, 2243.08%2.31%
30 Jun, 2243.19%2.18%
31 Mar, 2244.48%2.43%
31 Dec, 2142.75%2.39%
30 Sep, 2142.26%2.39%
30 Jun, 2142.07%2.33%
31 Mar, 2142.46%2.22%
31 Dec, 2043.72%2.31%
30 Sep, 2043.48%3.26%
30 Jun, 2036.50%3.57%
31 Mar, 2031.97%4.09%
31 Dec, 1927.96%3.48%
30 Sep, 1928.34%3.06%
30 Jun, 1930.43%3.06%
31 Mar, 1931.53%3.93%
31 Dec, 1828.31%3.20%
30 Sep, 1829.76%0.43%
30 Jun, 1883.04%-

As of 31 Mar 24, Kiniksa Pharmaceuticals is held by 55.34% institutional shareholders, representing a 2.33% growth compared to 31 Dec 23.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 248525.00%
31 Dec, 2368-
30 Sep, 2368-
30 Jun, 2368-12.82%
31 Mar, 23788.33%
31 Dec, 227220.00%
30 Sep, 226039.53%
30 Jun, 2243-10.42%
31 Mar, 2248-22.58%
31 Dec, 216210.71%
30 Sep, 21567.69%
30 Jun, 21524.00%
31 Mar, 2150-19.35%
31 Dec, 2062-17.33%
30 Sep, 20754.17%
30 Jun, 207263.64%
31 Mar, 20447.32%
31 Dec, 194151.85%
30 Sep, 1927-30.77%
30 Jun, 1939-2.50%
31 Mar, 194060.00%
31 Dec, 1825-32.43%
30 Sep, 1837-9.76%
30 Jun, 1841-

85 institutional shareholders have increased their position in KNSA stock as of 31 Mar 24 compared to 68 in the previous quarter (a 25.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 2448-14.29%
31 Dec, 235624.44%
30 Sep, 23457.14%
30 Jun, 234223.53%
31 Mar, 2334-2.86%
31 Dec, 223520.69%
30 Sep, 222911.54%
30 Jun, 2226-10.34%
31 Mar, 222911.54%
31 Dec, 2126-
30 Sep, 2126-16.13%
30 Jun, 2131-20.51%
31 Mar, 213944.44%
31 Dec, 202768.75%
30 Sep, 201614.29%
30 Jun, 2014-41.67%
31 Mar, 2024100.00%
31 Dec, 1912-20.00%
30 Sep, 191515.38%
30 Jun, 1913160.00%
31 Mar, 195-66.67%
31 Dec, 181550.00%
30 Sep, 1810-
30 Jun, 18--

48 institutional shareholders have reduced their position in KNSA stock as of 31 Mar 24 compared to 56 in the previous quarter (a -14.29% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 241608.84%38,944,11213.89%55.34%2.33%8525.00%48-14.29%
31 Dec, 231473.52%34,195,892-1.41%48.72%1.98%68-5624.44%
30 Sep, 231426.77%34,684,4169.13%49.61%2.39%68-457.14%
30 Jun, 23133-3.62%31,782,4990.21%45.57%2.20%68-12.82%4223.53%
31 Mar, 231383.76%31,715,9274.86%45.47%2.41%788.33%34-2.86%
31 Dec, 2213317.70%30,244,9341.09%43.45%2.34%7220.00%3520.69%
30 Sep, 2211318.95%29,920,261-0.02%43.08%2.31%6039.53%2911.54%
30 Jun, 2295-5.94%29,927,684-2.67%43.19%2.18%43-10.42%26-10.34%
31 Mar, 22101-5.61%30,749,7174.89%44.48%2.43%48-22.58%2911.54%
31 Dec, 211070.94%29,316,4171.04%42.75%2.39%6210.71%26-
30 Sep, 21106-6.19%29,014,1350.83%42.26%2.39%567.69%26-16.13%
30 Jun, 21113-1.74%28,774,053-0.74%42.07%2.33%524.00%31-20.51%
31 Mar, 211151.77%28,987,548-2.59%42.46%2.22%50-19.35%3944.44%
31 Dec, 201134.63%29,759,7753.78%43.72%2.31%62-17.33%2768.75%
30 Sep, 2010813.68%28,676,86335.67%43.48%3.26%754.17%1614.29%
30 Jun, 209525.00%21,136,79419.49%36.50%3.57%7263.64%14-41.67%
31 Mar, 207624.59%17,688,96617.04%31.97%4.09%447.32%24100.00%
31 Dec, 196115.09%15,113,844-2.72%27.96%3.48%4151.85%12-20.00%
30 Sep, 1953-13.11%15,536,525-6.27%28.34%3.06%27-30.77%1515.38%
30 Jun, 19618.93%16,575,9831.56%30.43%3.06%39-2.50%13160.00%
31 Mar, 19567.69%16,320,89318.97%31.53%3.93%4060.00%5-66.67%
31 Dec, 1852-3.70%13,718,366-4.87%28.31%3.20%25-32.43%1550.00%
30 Sep, 185431.71%14,420,957-16.46%29.76%0.43%37-9.76%10-
30 Jun, 1841-17,262,299-83.04%-41---

Kiniksa Pharmaceuticals Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 07, 2024Levy Richard Sdirector-M-ExemptSell747---
Apr 30, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERF-InKindSell509$17.88$9.10K19,253
Apr 08, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOF-InKindSell4,075$17.90$72.94K63,012
Apr 08, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOM-ExemptSell9,992--34,401
Apr 08, 2024Paolini John F.officer CHIEF MEDICAL OFFICERF-InKindSell733$17.90$13.12K47,803
Apr 08, 2024Paolini John F.officer CHIEF MEDICAL OFFICERM-ExemptSell2,497--9,375

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
May 07, 2024Levy Richard Sdirector-M-ExemptBuy747--8,524
May 07, 2024Levy Richard Sdirector-A-AwardBuy747--747
May 07, 2024Levy Richard Sdirector-M-ExemptSell747---
Apr 30, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERM-ExemptBuy991--19,762
Apr 30, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERF-InKindSell509$17.88$9.10K19,253
Apr 30, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERM-ExemptBuy991--990
Apr 08, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOA-AwardBuy129,750$18.06$2.34M129,750
Apr 08, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOM-ExemptBuy9,992--67,087
Apr 08, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOF-InKindSell4,075$17.90$72.94K63,012
Apr 08, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOA-AwardBuy24,950--44,393
Apr 08, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOM-ExemptSell9,992--34,401
Apr 08, 2024Patel Sanj Kdirector, officer CHAIRMAN & CEOA-AwardBuy20,000--20,000
Apr 08, 2024Paolini John F.officer CHIEF MEDICAL OFFICERM-ExemptBuy2,497--48,536
Apr 08, 2024Paolini John F.officer CHIEF MEDICAL OFFICERF-InKindSell733$17.90$13.12K47,803
Apr 08, 2024Paolini John F.officer CHIEF MEDICAL OFFICERA-AwardBuy36,350$18.06$656.48K36,350
Apr 08, 2024Paolini John F.officer CHIEF MEDICAL OFFICERA-AwardBuy7,000--11,872
Apr 08, 2024Paolini John F.officer CHIEF MEDICAL OFFICERM-ExemptSell2,497--9,375
Apr 08, 2024Paolini John F.officer CHIEF MEDICAL OFFICERA-AwardBuy5,600--5,600
Apr 08, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERA-AwardBuy33,150$18.06$598.69K33,150
Apr 08, 2024Ragosa Markofficer CHIEF FINANCIAL OFFICERM-ExemptBuy2,694--19,562

The last insider sell of Kiniksa Pharmaceuticals's stock was made by Levy Richard S on May 07 2024, selling 747 shares at - per share (valued at -).

Kiniksa Pharmaceuticals Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 20242924120.83%
Q1 202491947.37%
Q4 202351050.00%
Q3 2023283093.33%
Q2 20234713361.54%
Q1 2023142458.33%
Q4 20223650.00%
Q3 20221412116.67%
Q2 20222521250.00%
Q1 2022122352.17%
Q4 20211--
Q3 202117--
Q2 202192437.50%
Q1 20212411218.18%
Q4 202051729.41%
Q3 202092450.00%
Q2 2020117157.14%
Q1 2020101662.50%
Q4 201942200.00%
Q3 201961600.00%

29 total buy trades, and 24 total sell trades (buy/sell ratio of 1.21%) were made by Kiniksa Pharmaceuticals's insiders, as of Q2 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q2 2024---
Q1 2024-11-
Q4 2023-5-
Q3 2023-4-
Q2 2023---
Q1 2023---
Q4 2022-2-
Q3 2022---
Q2 2022---
Q1 2022---
Q4 2021---
Q3 2021---
Q2 2021---
Q1 2021-7-
Q4 2020-4-
Q3 2020-2-
Q2 2020-5-
Q1 2020-7-
Q4 2019---
Q3 2019---

As of Q2 2024, Insider owners conducted 0 open market buy trades and 0 open market sell trades of Kiniksa Pharmaceuticals's stocks.

Kiniksa Pharmaceuticals Peer Ownership


TickerCompany
GRCLGracell Biotechnologies Inc.
VTYXVentyx Biosciences, Inc.
NUVLNuvalent, Inc.
SPROSpero Therapeutics, Inc.
CERECerevel Therapeutics Holdings, Inc.
NVCTNuvectis Pharma, Inc.
DAWNDay One Biopharmaceuticals, Inc.
GPCRStructure Therapeutics Inc.
GOSSGossamer Bio, Inc.
CGEMCullinan Oncology, Inc.
COGTCogent Biosciences, Inc.
LRMRLarimar Therapeutics, Inc.
BOLTBolt Biotherapeutics, Inc.
ACLXArcellx, Inc.
NLTXNeurogene Inc.
KURAKura Oncology, Inc.
PHATPhathom Pharmaceuticals, Inc.
CHRSCoherus BioSciences, Inc.
KRTXKaruna Therapeutics, Inc.
LYRALyra Therapeutics, Inc.
KRONKronos Bio, Inc.
REPLReplimune Group, Inc.

KNSA Ownership FAQ


Kiniksa Pharmaceuticals is owned by institutional shareholders (55.34%), insiders (4.28%), and public (40.38%). The largest institutional shareholder of Kiniksa Pharmaceuticals is BLACKROCK INC. (5.96% of total shares) and the top mutual fund owner is WANGER ADVISORS TRUST (0.43% of total shares).

Kiniksa Pharmaceuticals's major institutional shareholders are BLACKROCK INC., FAIRMOUNT FUNDS MANAGEMENT LLC, HHLR ADVISORS, LTD., VANGUARD GROUP INC, and BAKER BROS. ADVISORS LP. The top five shareholders own together 23.20% of the company's share outstanding.

As of Mar 2024, there are 160 institutional shareholders of Kiniksa Pharmaceuticals.

BLACKROCK INC owns 4.19M shares of Kiniksa Pharmaceuticals, representing 5.96% of the company's total shares outstanding, valued at $82.75M (as of Mar 2024).

As of Mar 2024, FAIRMOUNT FUNDS MANAGEMENT LLC holds 3.2M shares of Kiniksa Pharmaceuticals (KNSA), compromising 4.55% of the company, valued at $63.23M.

HHLR ADVISORS, LTD is the third largest holder of Kiniksa Pharmaceuticals. The company owns 3.14M of the company's shares outstanding (worth $61.87M).